QuadraMed names new chairman

Michael Bassett | | Health Imaging | Artificial Intelligence
QuadraMed has named James E. Peebles chairman of its board of directors, replacing Robert Pevenstein, who has served as chairman for the last three and one-half years.

Peebles' move into the chairmanship follows closely on the heels of the appointment of Duncan James to be CEO of the the Reston-Va.-based health IT developer.

“Bob Pevenstein has done an outstanding job, and I will continue to rely heavily on him for guidance and assistance. I am also looking forward to working with Duncan James as I am confident that the expertise and strategy that he brings to the team will continue to strengthen QuadraMed’s prestige in the healthcare industry,” said Peebles.

Pebbles will remain as the chairman of the audit committee.

Michael Bassett,

Contributor

Related Content

Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.